Venrock Healthcare Capital Partners III, L.P.
Related Filers (44)
- VHCP Management III, LLC (48)
- Shah Nimish P (48)
- VHCP Co-Investment Holdings III, LLC (48)
- Koh Bong Y (43)
- VHCP Co-Investment Holdings II, LLC (33)
- VHCP Management II, LLC (33)
- Venrock Healthcare Capital Partners II, L.P. (33)
- Venrock Healthcare Capital Partners EG, L.P. (33)
- VHCP Management EG, LLC (33)
- Tricida, Inc. (21)
- KalVista Pharmaceuticals, Inc. (15)
- VENROCK ASSOCIATES IV L P (5)
- Bellerophon Therapeutics, Inc. (5)
- Altimmune, Inc. (4)
- Viridian Therapeutics, Inc.\DE (4)
- Milestone Pharmaceuticals Inc. (3)
- Terns Pharmaceuticals, Inc. (3)
- CONSTELLATION PHARMACEUTICALS INC (2)
- Trillium Therapeutics Inc. (2)
- Unum Therapeutics Inc. (2)
- Galera Therapeutics, Inc. (2)
- VistaGen Therapeutics, Inc. (2)
- Cabaletta Bio, Inc. (2)
- Avalo Therapeutics, Inc. (2)
- Enliven Therapeutics, Inc. (2)
- Applied Therapeutics Inc. (2)
- 4D Molecular Therapeutics, Inc. (2)
- Praxis Precision Medicines, Inc. (2)
- Spyre Therapeutics, Inc. (2)
- Adverum Biotechnologies, Inc. (2)
- Mersana Therapeutics, Inc. (2)
- Taysha Gene Therapies, Inc. (2)
- RayzeBio, Inc. (2)
- Abivax S.A. (2)
- Pharvaris N.V. (2)
- Cardiff Oncology, Inc. (1)
- Ambrx Biopharma Inc. (1)
- Apogee Therapeutics, Inc. (1)
- Dianthus Therapeutics, Inc. /DE/ (1)
- OCULAR THERAPEUTIX, INC (1)
- Astria Therapeutics, Inc. (1)
- Oric Pharmaceuticals, Inc. (1)
- Celcuity Inc. (1)
- Ambrx Biopharma, Inc. (1)
- Show More ...
Ownership (100)
SC 13G/A
Wednesday, 2/14/2024
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Avalo Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Cabaletta Bio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
4D Molecular Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
KalVista Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Applied Therapeutics Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
RayzeBio, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Celcuity Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Praxis Precision Medicines, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Ambrx Biopharma, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Abivax S.A.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Terns Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Pharvaris N.V.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Spyre Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Taysha Gene Therapies, Inc.: Major Shareholders
4
Thursday, 2/8/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/1/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 2/1/2024
Oric Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 1/29/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/24/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/19/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/10/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 1/2/2024
Astria Therapeutics, Inc.: Major Shareholders
4
Friday, 12/29/2023
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 12/28/2023
OCULAR THERAPEUTIX, INC: Major Shareholders
3
Thursday, 12/28/2023
KalVista Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Thursday, 12/28/2023
KalVista Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Thursday, 11/30/2023
Pharvaris N.V.: Major Shareholders
SC 13G
Wednesday, 11/22/2023
Abivax S.A.: Major Shareholders
SC 13G
Friday, 9/29/2023
RayzeBio, Inc.: Major Shareholders
SC 13G
Thursday, 9/21/2023
Dianthus Therapeutics, Inc. /DE/: Major Shareholders
SC 13G
Monday, 8/28/2023
Taysha Gene Therapies, Inc.: Major Shareholders
SC 13G
Monday, 8/7/2023
Mersana Therapeutics, Inc.: Major Shareholders
SC 13D
Friday, 7/28/2023
Apogee Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 7/24/2023
Adverum Biotechnologies, Inc.: Major Shareholders
SC 13G
Monday, 7/10/2023
Aeglea BioTherapeutics, Inc.: Major Shareholders
SC 13G
Friday, 6/30/2023
Praxis Precision Medicines, Inc.: Major Shareholders
SC 13G
Monday, 5/15/2023
4D Molecular Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 5/8/2023
Applied Therapeutics Inc.: Major Shareholders
SC 13G
Monday, 3/13/2023
Enliven Therapeutics, Inc.: Major Shareholders
SC 13G
Monday, 2/27/2023
Ambrx Biopharma Inc.: Major Shareholders
SC 13G
Friday, 2/17/2023
Avalo Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Terns Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Milestone Pharmaceuticals Inc.: Major Shareholders
SC 13G
Monday, 1/9/2023
KalVista Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Friday, 12/23/2022
Cabaletta Bio, Inc.: Major Shareholders
4
Wednesday, 10/26/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/11/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/3/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/28/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 9/20/2022
Milestone Pharmaceuticals Inc.: Major Shareholders
4
Wednesday, 9/7/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/1/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 8/29/2022
Terns Pharmaceuticals, Inc.: Major Shareholders
4
Tuesday, 8/2/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/25/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/20/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/14/2022
VistaGen Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/14/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 7/8/2022
VistaGen Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/6/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/30/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/24/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 6/6/2022
Tricida, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/6/2022
Tricida, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Viridian Therapeutics, Inc.\DE: Major Shareholders
SC 13G
Thursday, 10/14/2021
Viridian Therapeutics, Inc.\DE: Major Shareholders
4
Monday, 3/1/2021
Altimmune, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
Galera Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Trillium Therapeutics Inc.: Major Shareholders
SC 13G
Wednesday, 11/4/2020
Galera Therapeutics, Inc.: Major Shareholders
SC 13G
Wednesday, 11/4/2020
Cardiff Oncology, Inc.: Major Shareholders
4
Tuesday, 8/18/2020
Unum Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/18/2020
Unum Therapeutics Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/15/2020
Altimmune, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/28/2020
Altimmune, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/28/2020
Altimmune, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 1/21/2020
Trillium Therapeutics Inc.: Major Shareholders
4
Monday, 12/16/2019
CONSTELLATION PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/28/2019
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 10/4/2019
CONSTELLATION PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities
4
Wednesday, 3/20/2019
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/14/2019
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/17/2018
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/12/2018
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 9/10/2018
KalVista Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 9/7/2018
Bellerophon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities